Valuation: Gedeon Richter

Market Cap 2,276B 7.11B 6.24B 5.89B 5.37B 10.06B 681B 10.12B 70.5B 27.26B 348B 26.69B 26.1B 1,117B P/E 2026 *
9.18x
P/E 2027 * 7.85x
Enterprise Value 2,014B 6.29B 5.52B 5.21B 4.75B 8.9B 602B 8.95B 62.37B 24.12B 308B 23.61B 23.09B 989B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.83x
Free-Float
72.87%
Yield 2026 *
4.84%
Yield 2027 * 5.42%
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 01/11/2017
Director of Finance/CFO - 01/05/2025
Chief Operating Officer - 01/01/2019
Director TitleAgeSince
Chairman 78 01/01/2017
Chairman 90 01/03/2024
Director/Board Member 65 26/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 7.09B
+0.12%+0.81%+13.81%+64.78% 46.37B
+1.09%+0.36%+39.50%+107.67% 37.26B
+2.00%+3.78%+18.12%+99.54% 12.53B
+0.05%+0.37%-7.29%+18.68% 11.8B
0.00%0.00%+18.72%+139.63% 8.97B
-1.34%-2.73%+27.67%+37.52% 7.09B
-2.07%-2.75%+17.20%+202.97% 7.01B
+1.43%+2.22%+43.10%-14.21% 7.29B
-2.45%-0.59%-51.49%+4.53% 4.99B
Average +2.33%+0.16%+13.26%+73.46% 15.92B
Weighted average by Cap. +1.46%+0.54%+19.51%+79.15%

Financials

2026 *2027 *
Net sales 951B 2.97B 2.61B 2.46B 2.24B 4.2B 285B 4.23B 29.47B 11.4B 145B 11.15B 10.91B 467B 1,021B 3.19B 2.8B 2.64B 2.41B 4.51B 305B 4.54B 31.62B 12.23B 156B 11.97B 11.71B 501B
Net income 254B 794M 697M 658M 599M 1.12B 76.08B 1.13B 7.88B 3.05B 38.87B 2.98B 2.92B 125B 291B 907M 797M 751M 685M 1.28B 86.92B 1.29B 9B 3.48B 44.41B 3.41B 3.33B 143B
Net Debt -262B -819M -720M -679M -619M -1.16B -78.52B -1.17B -8.13B -3.14B -40.12B -3.08B -3.01B -129B -410B -1.28B -1.12B -1.06B -966M -1.81B -123B -1.82B -12.7B -4.91B -62.67B -4.81B -4.7B -201B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,480.00HUF
Average target price
13,214.57HUF
Spread / Average Target
+5.89%

Quarterly revenue - Rate of surprise